May 24, 2019
Philip Morris International to Invest up to €500 Million in Reduced-Risk Product Manufacturing Facility in Italy
“The development and commercialization of reduced-risk products
represents a significant step toward achieving the public health
objective of harm reduction, a potential paradigm shift for the
industry, and an important growth opportunity for PMI. This first
factory investment is a milestone in our roadmap toward making these
products available to adult smokers," said André Calantzopoulos,
PMI’s Chief Executive Officer. "This investment underscores our
strong commitment to
Construction on the new facility is expected to begin immediately and last approximately two years. Once fully operational it will employ up to 600 people. The pilot plant is already near completion and will serve as the production facility for pilot and initial market launches. Importantly, the majority of the construction and manufacturing equipment will be procured from Italian companies and further benefit the country’s economy.
PMI’s investment in the development and rigorous scientific assessment
of products with the potential to reduce the risks of smoking spans more
than a decade. It encompasses a wide-range of tobacco and non-tobacco
containing product platforms. In
Separately, PMI in
Source:
Philip Morris International
Investor Relations:
New York: +1
(917) 663 2233
Lausanne: +41 (0)58 242 4666
or
Media:
Lausanne:
+41 (0)58 242 4500
Sign up for more information from PMI's Investor Relations team.
Get updates from our Investor Relations team
New PMI Investor Relations mobile app is now available
Our newly designed Investor Relations mobile application provides users with easier, more dynamic and comprehensive access to the company’s Investor Relations information, such as stock quotes, press releases, SEC filings, investor materials, and live and archived webcast playback of earnings calls and investor presentations.